Investment - Banking & Investment Services
Compare Stocks
5 / 10Stock Comparison
UCFI vs GAIN vs HRZN vs ARCC vs FSCO
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
UCFI vs GAIN vs HRZN vs ARCC vs FSCO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Investment - Banking & Investment Services | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $288M | $657M | $199M | $13.61B | $1.02B |
| Revenue (TTM) | $11M | $90M | $40M | $3.15B | $254M |
| Net Income (TTM) | $4M | $130M | $28M | $1.15B | $188M |
| Gross Margin | 66.5% | 68.6% | 18.0% | 75.7% | 81.3% |
| Operating Margin | 48.8% | 72.7% | -4.0% | 69.7% | 77.5% |
| Forward P/E | — | 40.7x | 6.1x | 9.9x | 5.4x |
| Total Debt | $0.00 | $456M | $473M | $15.99B | $453M |
| Cash & Equiv. | $41M | $14M | $106M | $924M | $189M |
UCFI vs GAIN vs HRZN vs ARCC vs FSCO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 25 | Mar 26 | Return |
|---|---|---|---|
| United Financial In… (UCFI) | 100 | 134.7 | +34.7% |
| Gladstone Investmen… (GAIN) | 100 | 97.9 | -2.1% |
| Horizon Technology … (HRZN) | 100 | 45.3 | -54.7% |
| Ares Capital Corpor… (ARCC) | 100 | 94.8 | -5.2% |
| FS Credit Opportuni… (FSCO) | 100 | 97.3 | -2.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UCFI vs GAIN vs HRZN vs ARCC vs FSCO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UCFI is the clearest fit if your priority is long-term compounding.
- 330.5% 10Y total return vs GAIN's 319.3%
GAIN has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.53, Low D/E 91.3%, current ratio 3.69x
- Beta 0.53 vs ARCC's 0.77, lower leverage
- +30.8% vs UCFI's -45.4%
HRZN is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 17.9%, EPS growth 7.6%
- PEG 0.26 vs ARCC's 0.96
- Lower P/E (6.1x vs 9.9x), PEG 0.26 vs 0.96
- 27.8% yield, vs FSCO's 13.9%, (1 stock pays no dividend)
ARCC is the clearest fit if your priority is growth.
- 32.9% NII/revenue growth vs FSCO's -17.4%
FSCO ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 3 yrs, beta 0.64, yield 13.9%
- Beta 0.64, yield 13.9%, current ratio 5.84x
- NIM 8.9% vs UCFI's 0.1%
- Efficiency ratio 0.0% vs HRZN's 0.2% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% NII/revenue growth vs FSCO's -17.4% | |
| Value | Lower P/E (6.1x vs 9.9x), PEG 0.26 vs 0.96 | |
| Quality / Margins | Efficiency ratio 0.0% vs HRZN's 0.2% (lower = leaner) | |
| Stability / Safety | Beta 0.53 vs ARCC's 0.77, lower leverage | |
| Dividends | 27.8% yield, vs FSCO's 13.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +30.8% vs UCFI's -45.4% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs HRZN's 0.2% |
UCFI vs GAIN vs HRZN vs ARCC vs FSCO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FSCO leads in 1 of 6 categories
HRZN leads 1 • UCFI leads 1 • GAIN leads 1 • ARCC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FSCO leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 277.2x UCFI's $11M. FSCO is the more profitable business, keeping 74.2% of every revenue dollar as net income compared to HRZN's -6.6%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11M | $90M | $40M | $3.1B | $254M |
| EBITDAEarnings before interest/tax | — | $58M | $19M | $2.0B | — |
| Net IncomeAfter-tax profit | — | $130M | $28M | $1.1B | — |
| Free Cash FlowCash after capex | — | -$82M | $67M | $1.1B | — |
| Gross MarginGross profit ÷ Revenue | +66.5% | +68.6% | +18.0% | +75.7% | +81.3% |
| Operating MarginEBIT ÷ Revenue | +48.8% | +72.7% | -4.0% | +69.7% | +77.5% |
| Net MarginNet income ÷ Revenue | +35.2% | +72.7% | -6.6% | +41.3% | +74.2% |
| FCF MarginFCF ÷ Revenue | +3.7% | +126.8% | +141.5% | +36.3% | +26.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +58.1% | -29.6% | -63.9% | — |
Valuation Metrics
HRZN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 4.3x trailing earnings, HRZN trades at a 58% valuation discount to ARCC's 10.2x P/E. Adjusting for growth (PEG ratio), HRZN offers better value at 0.18x vs ARCC's 0.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $288M | $657M | $199M | $13.6B | $1.0B |
| Enterprise ValueMkt cap + debt − cash | $246M | $1.1B | $567M | $28.7B | $1.3B |
| Trailing P/EPrice ÷ TTM EPS | — | 9.28x | 4.30x | 10.19x | 5.42x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 40.66x | 6.10x | 9.92x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.18x | 0.99x | — |
| EV / EBITDAEnterprise value multiple | 42.95x | 16.82x | — | 13.09x | 6.53x |
| Price / SalesMarket cap ÷ Revenue | 25.36x | 7.31x | 4.97x | 4.33x | 4.02x |
| Price / BookPrice ÷ Book value/share | — | 1.22x | 0.60x | 0.93x | 0.72x |
| Price / FCFMarket cap ÷ FCF | 6.84x | 5.77x | 3.51x | 11.92x | 15.21x |
Profitability & Efficiency
UCFI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
UCFI delivers a 37.0% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $8 for ARCC. FSCO carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to HRZN's 1.49x. On the Piotroski fundamental quality scale (0–9), UCFI scores 7/9 vs FSCO's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +37.0% | +21.9% | +9.0% | +8.1% | +13.5% |
| ROA (TTM)Return on assets | +7.9% | +10.5% | +3.6% | +3.8% | +8.5% |
| ROICReturn on invested capital | +38.4% | +5.3% | -0.2% | +5.7% | +8.1% |
| ROCEReturn on capital employed | +51.3% | +6.8% | -0.2% | +7.5% | +9.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 5 | 4 | 3 |
| Debt / EquityFinancial leverage | — | 0.91x | 1.49x | 1.12x | 0.32x |
| Net DebtTotal debt minus cash | -$41M | $441M | $368M | $15.1B | $264M |
| Cash & Equiv.Liquid assets | $41M | $14M | $106M | $924M | $189M |
| Total DebtShort + long-term debt | $0 | $456M | $473M | $16.0B | $453M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.58x | 0.60x | 2.98x | 4.14x |
Total Returns (Dividends Reinvested)
Evenly matched — UCFI and GAIN and FSCO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UCFI five years ago would be worth $84,769 today (with dividends reinvested), compared to $6,724 for HRZN. Over the past 12 months, GAIN leads with a +30.8% total return vs UCFI's -45.4%. The 3-year compound annual growth rate (CAGR) favors FSCO at 19.7% vs UCFI's -18.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | 0.0% | +20.7% | -26.7% | -4.9% | -15.0% |
| 1-Year ReturnPast 12 months | -45.4% | +30.8% | -23.2% | +0.4% | -16.4% |
| 3-Year ReturnCumulative with dividends | -45.4% | +56.5% | -27.7% | +34.2% | +71.3% |
| 5-Year ReturnCumulative with dividends | +747.7% | +72.0% | -32.8% | +47.0% | +70.5% |
| 10-Year ReturnCumulative with dividends | +330.5% | +319.3% | +52.9% | +139.2% | +70.5% |
| CAGR (3Y)Annualised 3-year return | -18.3% | +16.1% | -10.3% | +10.3% | +19.7% |
Risk & Volatility
GAIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than ARCC's 0.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 96.3% from its 52-week high vs UCFI's 50.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | — | 0.53x | 0.70x | 0.77x | 0.64x |
| 52-Week HighHighest price in past year | $11.00 | $17.14 | $8.46 | $23.42 | $7.65 |
| 52-Week LowLowest price in past year | $3.41 | $13.11 | $3.80 | $17.40 | $4.13 |
| % of 52W HighCurrent price vs 52-week peak | +50.1% | +96.3% | +53.3% | +81.0% | +67.3% |
| RSI (14)Momentum oscillator 0–100 | 33.5 | 69.9 | 58.5 | 56.7 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 0 | 371K | 1.2M | 7.5M | 2.0M |
Analyst Outlook
Evenly matched — HRZN and FSCO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GAIN as "Hold", HRZN as "Hold", ARCC as "Buy". Consensus price targets imply 44.1% upside for HRZN (target: $7) vs -9.1% for GAIN (target: $15). For income investors, HRZN offers the higher dividend yield at 27.80% vs ARCC's 2.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | — |
| Price TargetConsensus 12-month target | — | $15.00 | $6.50 | $21.88 | — |
| # AnalystsCovering analysts | — | 7 | 22 | 32 | — |
| Dividend YieldAnnual dividend ÷ price | — | +10.0% | +27.8% | +2.0% | +13.9% |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 0 | 3 |
| Dividend / ShareAnnual DPS | — | $1.66 | $1.25 | $0.38 | $0.72 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
FSCO leads in 1 of 6 categories (Income & Cash Flow). HRZN leads in 1 (Valuation Metrics). 2 tied.
UCFI vs GAIN vs HRZN vs ARCC vs FSCO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UCFI or GAIN or HRZN or ARCC or FSCO a better buy right now?
For growth investors, Ares Capital Corporation (ARCC) is the stronger pick with 32.
9% revenue growth year-over-year, versus -17. 4% for FS Credit Opportunities Corp. (FSCO). Horizon Technology Finance Corporation (HRZN) offers the better valuation at 4. 3x trailing P/E (6. 1x forward), making it the more compelling value choice. Analysts rate Ares Capital Corporation (ARCC) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UCFI or GAIN or HRZN or ARCC or FSCO?
On trailing P/E, Horizon Technology Finance Corporation (HRZN) is the cheapest at 4.
3x versus Ares Capital Corporation at 10. 2x. On forward P/E, Horizon Technology Finance Corporation is actually cheaper at 6. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Horizon Technology Finance Corporation wins at 0. 26x versus Ares Capital Corporation's 0. 96x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — UCFI or GAIN or HRZN or ARCC or FSCO?
Over the past 5 years, United Financial Investments Company PSC (UCFI) delivered a total return of +747.
7%, compared to -32. 8% for Horizon Technology Finance Corporation (HRZN). Over 10 years, the gap is even starker: UCFI returned +330. 5% versus HRZN's +52. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UCFI or GAIN or HRZN or ARCC or FSCO?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
53β versus Ares Capital Corporation's 0. 77β — meaning ARCC is approximately 44% more volatile than GAIN relative to the S&P 500. On balance sheet safety, FS Credit Opportunities Corp. (FSCO) carries a lower debt/equity ratio of 32% versus 149% for Horizon Technology Finance Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — UCFI or GAIN or HRZN or ARCC or FSCO?
By revenue growth (latest reported year), Ares Capital Corporation (ARCC) is pulling ahead at 32.
9% versus -17. 4% for FS Credit Opportunities Corp. (FSCO). On earnings-per-share growth, the picture is similar: Horizon Technology Finance Corporation grew EPS 756. 3% year-over-year, compared to -27. 9% for Gladstone Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UCFI or GAIN or HRZN or ARCC or FSCO?
FS Credit Opportunities Corp.
(FSCO) is the more profitable company, earning 74. 2% net margin versus -6. 6% for Horizon Technology Finance Corporation — meaning it keeps 74. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FSCO leads at 77. 5% versus -4. 0% for HRZN. At the gross margin level — before operating expenses — FSCO leads at 81. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UCFI or GAIN or HRZN or ARCC or FSCO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Horizon Technology Finance Corporation (HRZN) is the more undervalued stock at a PEG of 0. 26x versus Ares Capital Corporation's 0. 96x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Horizon Technology Finance Corporation (HRZN) trades at 6. 1x forward P/E versus 40. 7x for Gladstone Investment Corporation — 34. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HRZN: 44. 1% to $6. 50.
08Which pays a better dividend — UCFI or GAIN or HRZN or ARCC or FSCO?
In this comparison, HRZN (27.
8% yield), FSCO (13. 9% yield), GAIN (10. 0% yield), ARCC (2. 0% yield) pay a dividend. UCFI does not pay a meaningful dividend and should not be held primarily for income.
09Is UCFI or GAIN or HRZN or ARCC or FSCO better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, UCFI: +330. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UCFI and GAIN and HRZN and ARCC and FSCO?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UCFI is a small-cap quality compounder stock; GAIN is a small-cap deep-value stock; HRZN is a small-cap high-growth stock; ARCC is a mid-cap high-growth stock; FSCO is a small-cap deep-value stock. GAIN, HRZN, ARCC, FSCO pay a dividend while UCFI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 8%
- Dividend Yield > 11.1%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.